Variant serum β-hexosaminidase as a biochemical marker of malignancy
✍ Scribed by Mark C. Plucinsky; Joseph J. Prorok; Jack A. Alhadeff
- Publisher
- John Wiley and Sons
- Year
- 1986
- Tongue
- English
- Weight
- 408 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A prospective study was done to evaluate the roles of serum N-acetylneuraminic acid (NANA) and the lipid-bound subfraction of sialic acid (LSA) concentrations in the detection and staging of cancer, and the follow-up of treatment in patients with genitourinary malignancies. Multiple determinations w
## Background: Malignant diseases of various origins were previously shown to be associated with a characteristic and highly significant change in the serum pattern of immunoglobulin (ig)g subclasses, comprised of a decrease in %igg1 and an increase in %igg2 relative to and independent of the absol
The P chain of human chorionic gonadotropin (hCG) hormone is produced by fetal cells, gonadal cell tumors and several types of non-gonadal carcinoma. hCG is composed of an Q and a P chain, the latter of which can be used to distinguish the molecule from other related gonadotropin hormones. Detection
This study was conducted to evaluate the clinical usefulness of serum hCG in the diagnosis and prognosis of patients (n ؍ 59) with cancers of the oral cavity and oropharynx. As a reference marker we used squamous-cell carcinoma antigen (SCCAg). A blood sample was obtained from all patients before